Dr. Cirstea is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114
Education & Training
Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Mount Auburn HospitalResidency, Internal Medicine, 2013 - 2016
Nicolae Testemitanu State University of Medicine and PharmacyClass of 2000
Certifications & Licensure
MA State Medical License 2013 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Early daratumumab therapy improves renal outcomes in newly diagnosed myeloma patients admitted with kidney injury.E Bridget Kim, Jack E Malespini, Matthew Lei, Samuel S Han, Cole W Minsky
Blood Advances. 2025-03-14 - Integration of clinical outcomes and molecular features in extramedullary disease in multiple myeloma.Rie Nakamoto-Matsubara, Valentina Nardi, Nora Horick, Tsuyoshi Fukushima, Ryan S Han
Blood Cancer Journal. 2024-12-23 - 3 citationsIsatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk): a single-arm, phase 2 t...Elizabeth O'Donnell, Clifton Mo, Andrew J Yee, Omar Nadeem, Jacob Laubach
The Lancet. Haematology. 2024-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
